H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Genetics and Molecular Biology H-index 180 Citations 236,393 364 World Ranking 19 National Ranking 14
Medicine H-index 195 Citations 269,933 490 World Ranking 70 National Ranking 50

Research.com Recognitions

Awards & Achievements

2020 - Fellow of the American Association for the Advancement of Science (AAAS)

2018 - Member of the National Academy of Medicine (NAM)

2009 - Paul Marks Prize for Cancer Research, Memorial Sloan Kettering Cancer Center

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Mutation

Matthew Meyerson mostly deals with Cancer research, Genetics, Cancer, Mutation and Gene. His Cancer research research is multidisciplinary, relying on both DNA methylation, Epidermal growth factor receptor, Immunology, microRNA and Lung cancer. Genome, Carcinogenesis, Human genome, Exome and Germline mutation are the primary areas of interest in his Genetics study.

His Cancer research incorporates elements of Exome sequencing, Gene expression profiling, Somatic cell, Gene dosage and Human genetics. His Gene expression profiling research is multidisciplinary, incorporating elements of Mesenchymal Glioblastoma, Computational biology and Bioinformatics. His Mutation research includes elements of Genome-wide association study, Melanoma, Neuroblastoma and Kinase.

His most cited work include:

  • EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. (7935 citations)
  • EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. (7935 citations)
  • Comprehensive molecular portraits of human breast tumours (7253 citations)

What are the main themes of his work throughout his whole career to date?

Matthew Meyerson focuses on Cancer research, Genetics, Cancer, Gene and Mutation. His biological study spans a wide range of topics, including Epidermal growth factor receptor, Carcinogenesis, KRAS, Lung cancer and Adenocarcinoma. His Epidermal growth factor receptor research integrates issues from Tyrosine kinase and Molecular biology.

His research in Adenocarcinoma intersects with topics in Lung and Gene expression profiling. Genetics is represented through his Genome, Human genome, Exome, Exome sequencing and Germline mutation research. His studies deal with areas such as Oncology, Bioinformatics and Pathology as well as Cancer.

He most often published in these fields:

  • Cancer research (58.21%)
  • Genetics (42.48%)
  • Cancer (37.89%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (58.21%)
  • Cancer (37.89%)
  • Gene (25.37%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, Cancer, Gene, Genetics and Computational biology. His work carried out in the field of Cancer research brings together such families of science as Oncogene, Mutant, KRAS, Colorectal cancer and Adenocarcinoma. The Colorectal cancer study combines topics in areas such as Carcinogenesis, Fusobacterium and Microsatellite instability.

He combines subjects such as SOS1, Lung and Gene expression profiling with his study of Adenocarcinoma. His Cancer study incorporates themes from Cell, Kinase and Oncology. His work deals with themes such as Genome, Human genome and Sequence analysis, which intersect with Computational biology.

Between 2016 and 2021, his most popular works were:

  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (865 citations)
  • Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (805 citations)
  • Oncogenic Signaling Pathways in The Cancer Genome Atlas (792 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His primary scientific interests are in Cancer research, Cancer, Gene, Genetics and Mutation. His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Colorectal cancer, microRNA and DNA methylation. The concepts of his Cancer study are interwoven with issues in Missense mutation and Oncology.

Genetics is often connected to Drug response in his work. His studies in Mutation integrate themes in fields like Bladder cancer, Molecular biology, Breast cancer and Promoter. The various areas that Matthew Meyerson examines in his Adenocarcinoma study include Lung cancer and Lung.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

J. Guillermo Paez;Pasi A. Jänne;Pasi A. Jänne;Jeffrey C. Lee;Sean Tracy.
Science (2004)

10881 Citations

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Roel G. W. Verhaak;Katherine A. Hoadley;Elizabeth Purdom;Victoria Wang.
Cancer Cell (2010)

7711 Citations

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Nature (2012)

6768 Citations

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
Nature (2013)

6684 Citations

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Jordi Barretina;Giordano Caponigro;Nicolas Stransky;Kavitha Venkatesan.
Nature (2012)

5391 Citations

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
Nature (2008)

5348 Citations

Comprehensive molecular characterization of human colon and rectal cancer

Donna M. Muzny;Matthew N. Bainbridge;Kyle Chang;Huyen H. Dinh.
Nature (2012)

4544 Citations

Integrated genomic analyses of ovarian carcinoma

D. Bell;A. Berchuck;M. Birrer;J. Chien.
Nature (2011)

4542 Citations

EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

Susumu Kobayashi;Titus J. Boggon;Tajhal Dayaram;Pasi A. Jänne.
The New England Journal of Medicine (2005)

4169 Citations

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds.
Nature (2014)

3915 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Matthew Meyerson

William C. Hahn

William C. Hahn

Harvard University

Publications: 342

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 332

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 322

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 262

Mark A. Rubin

Mark A. Rubin

University of Bern

Publications: 256

Gad Getz

Gad Getz

Broad Institute

Publications: 252

Levi A. Garraway

Levi A. Garraway

Harvard University

Publications: 244

Peter J. Campbell

Peter J. Campbell

Wellcome Sanger Institute

Publications: 231

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 224

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 224

Rameen Beroukhim

Rameen Beroukhim

Harvard University

Publications: 216

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 212

Vincent A. Miller

Vincent A. Miller

EQRx

Publications: 204

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 204

John D. Minna

John D. Minna

The University of Texas Southwestern Medical Center

Publications: 203

Something went wrong. Please try again later.